HEADER IMMUNE SYSTEM 07-SEP-22 8GT6 TITLE HUMAN STING WITH AGONIST HB3089 COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HSTING,ENDOPLASMIC RETICULUM INTERFERON STIMULATOR,ERIS, COMPND 5 MEDIATOR OF IRF3 ACTIVATION,HMITA,TRANSMEMBRANE PROTEIN 173; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING1, ERIS, MITA, STING, TMEM173; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS AGONIST, HUMAN STING, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR Z.WANG,X.YU REVDAT 1 28-DEC-22 8GT6 0 JRNL AUTH Z.XIE,Z.WANG,F.FAN,J.ZHOU,Z.HU,Q.WANG,X.WANG,Q.ZENG,Y.ZHANG, JRNL AUTH 2 J.QIU,X.ZHOU,H.XU,H.BAI,Z.ZHAN,J.DING,H.ZHANG,W.DUAN,X.YU, JRNL AUTH 3 M.GENG JRNL TITL STRUCTURAL INSIGHTS INTO A SHARED MECHANISM OF HUMAN STING JRNL TITL 2 ACTIVATION BY A POTENT AGONIST AND AN AUTOIMMUNE JRNL TITL 3 DISEASE-ASSOCIATED MUTATION. JRNL REF CELL DISCOV V. 8 133 2022 JRNL REFN ESSN 2056-5968 JRNL PMID 36513640 JRNL DOI 10.1038/S41421-022-00481-4 REMARK 2 REMARK 2 RESOLUTION. 3.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.470 REMARK 3 NUMBER OF PARTICLES : 91390 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8GT6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1300032086. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN STING WITH AGONIST HB3089 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 7000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 HIS A 3 REMARK 465 SER A 4 REMARK 465 GLY A 37 REMARK 465 GLU A 38 REMARK 465 PRO A 39 REMARK 465 LEU A 109 REMARK 465 PRO A 110 REMARK 465 ASN A 111 REMARK 465 ALA A 112 REMARK 465 VAL A 113 REMARK 465 GLY A 114 REMARK 465 PRO A 115 REMARK 465 ASN A 187 REMARK 465 ASN A 188 REMARK 465 LEU A 189 REMARK 465 LEU A 190 REMARK 465 GLY A 230 REMARK 465 ASP A 231 REMARK 465 HIS A 232 REMARK 465 ALA A 233 REMARK 465 GLY A 234 REMARK 465 ILE A 235 REMARK 465 LYS A 236 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 ASP A 320 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 GLY A 344 REMARK 465 SER A 345 REMARK 465 LEU A 346 REMARK 465 LYS A 347 REMARK 465 THR A 348 REMARK 465 SER A 349 REMARK 465 ALA A 350 REMARK 465 VAL A 351 REMARK 465 PRO A 352 REMARK 465 SER A 353 REMARK 465 THR A 354 REMARK 465 SER A 355 REMARK 465 THR A 356 REMARK 465 MET A 357 REMARK 465 SER A 358 REMARK 465 GLN A 359 REMARK 465 GLU A 360 REMARK 465 PRO A 361 REMARK 465 GLU A 362 REMARK 465 LEU A 363 REMARK 465 LEU A 364 REMARK 465 ILE A 365 REMARK 465 SER A 366 REMARK 465 GLY A 367 REMARK 465 MET A 368 REMARK 465 GLU A 369 REMARK 465 LYS A 370 REMARK 465 PRO A 371 REMARK 465 LEU A 372 REMARK 465 PRO A 373 REMARK 465 LEU A 374 REMARK 465 ARG A 375 REMARK 465 THR A 376 REMARK 465 ASP A 377 REMARK 465 PHE A 378 REMARK 465 SER A 379 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 HIS B 3 REMARK 465 SER B 4 REMARK 465 GLY B 37 REMARK 465 GLU B 38 REMARK 465 PRO B 39 REMARK 465 LEU B 109 REMARK 465 PRO B 110 REMARK 465 ASN B 111 REMARK 465 ALA B 112 REMARK 465 VAL B 113 REMARK 465 GLY B 114 REMARK 465 PRO B 115 REMARK 465 ASN B 187 REMARK 465 ASN B 188 REMARK 465 LEU B 189 REMARK 465 LEU B 190 REMARK 465 GLY B 230 REMARK 465 ASP B 231 REMARK 465 HIS B 232 REMARK 465 ALA B 233 REMARK 465 GLY B 234 REMARK 465 ILE B 235 REMARK 465 LYS B 236 REMARK 465 ALA B 318 REMARK 465 ASP B 319 REMARK 465 ASP B 320 REMARK 465 LYS B 338 REMARK 465 GLU B 339 REMARK 465 GLU B 340 REMARK 465 VAL B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 465 GLY B 344 REMARK 465 SER B 345 REMARK 465 LEU B 346 REMARK 465 LYS B 347 REMARK 465 THR B 348 REMARK 465 SER B 349 REMARK 465 ALA B 350 REMARK 465 VAL B 351 REMARK 465 PRO B 352 REMARK 465 SER B 353 REMARK 465 THR B 354 REMARK 465 SER B 355 REMARK 465 THR B 356 REMARK 465 MET B 357 REMARK 465 SER B 358 REMARK 465 GLN B 359 REMARK 465 GLU B 360 REMARK 465 PRO B 361 REMARK 465 GLU B 362 REMARK 465 LEU B 363 REMARK 465 LEU B 364 REMARK 465 ILE B 365 REMARK 465 SER B 366 REMARK 465 GLY B 367 REMARK 465 MET B 368 REMARK 465 GLU B 369 REMARK 465 LYS B 370 REMARK 465 PRO B 371 REMARK 465 LEU B 372 REMARK 465 PRO B 373 REMARK 465 LEU B 374 REMARK 465 ARG B 375 REMARK 465 THR B 376 REMARK 465 ASP B 377 REMARK 465 PHE B 378 REMARK 465 SER B 379 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 95 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 191 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 220 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 276 CG CD OE1 NE2 REMARK 470 GLU A 296 CG CD OE1 OE2 REMARK 470 ARG B 95 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 191 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 220 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 276 CG CD OE1 NE2 REMARK 470 GLU B 296 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 89 CA - CB - CG ANGL. DEV. = 14.7 DEGREES REMARK 500 LEU B 89 CA - CB - CG ANGL. DEV. = 14.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 89 -2.06 64.40 REMARK 500 ASN A 154 37.09 -97.98 REMARK 500 ALA A 156 -39.68 -132.51 REMARK 500 GLN A 196 51.77 -93.29 REMARK 500 ARG A 220 31.95 -140.20 REMARK 500 LEU A 248 60.14 -110.20 REMARK 500 ASN A 250 52.70 36.81 REMARK 500 SER A 305 35.34 -99.96 REMARK 500 ASN A 307 18.78 -141.53 REMARK 500 LEU B 89 -2.06 64.40 REMARK 500 ASN B 154 37.09 -97.98 REMARK 500 ALA B 156 -39.68 -132.51 REMARK 500 GLN B 196 51.77 -93.29 REMARK 500 ARG B 220 31.95 -140.20 REMARK 500 LEU B 248 60.14 -110.20 REMARK 500 ASN B 250 52.70 36.81 REMARK 500 SER B 305 35.34 -99.96 REMARK 500 ASN B 307 18.78 -141.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 205 CYS A 206 -136.05 REMARK 500 ASP B 205 CYS B 206 -136.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-34245 RELATED DB: EMDB REMARK 900 HUMAN STING WITH AGONIST HB3089 DBREF 8GT6 A 1 379 UNP Q86WV6 STING_HUMAN 1 379 DBREF 8GT6 B 1 379 UNP Q86WV6 STING_HUMAN 1 379 SEQRES 1 A 379 MET PRO HIS SER SER LEU HIS PRO SER ILE PRO CYS PRO SEQRES 2 A 379 ARG GLY HIS GLY ALA GLN LYS ALA ALA LEU VAL LEU LEU SEQRES 3 A 379 SER ALA CYS LEU VAL THR LEU TRP GLY LEU GLY GLU PRO SEQRES 4 A 379 PRO GLU HIS THR LEU ARG TYR LEU VAL LEU HIS LEU ALA SEQRES 5 A 379 SER LEU GLN LEU GLY LEU LEU LEU ASN GLY VAL CYS SER SEQRES 6 A 379 LEU ALA GLU GLU LEU ARG HIS ILE HIS SER ARG TYR ARG SEQRES 7 A 379 GLY SER TYR TRP ARG THR VAL ARG ALA CYS LEU GLY CYS SEQRES 8 A 379 PRO LEU ARG ARG GLY ALA LEU LEU LEU LEU SER ILE TYR SEQRES 9 A 379 PHE TYR TYR SER LEU PRO ASN ALA VAL GLY PRO PRO PHE SEQRES 10 A 379 THR TRP MET LEU ALA LEU LEU GLY LEU SER GLN ALA LEU SEQRES 11 A 379 ASN ILE LEU LEU GLY LEU LYS GLY LEU ALA PRO ALA GLU SEQRES 12 A 379 ILE SER ALA VAL CYS GLU LYS GLY ASN PHE ASN VAL ALA SEQRES 13 A 379 HIS GLY LEU ALA TRP SER TYR TYR ILE GLY TYR LEU ARG SEQRES 14 A 379 LEU ILE LEU PRO GLU LEU GLN ALA ARG ILE ARG THR TYR SEQRES 15 A 379 ASN GLN HIS TYR ASN ASN LEU LEU ARG GLY ALA VAL SER SEQRES 16 A 379 GLN ARG LEU TYR ILE LEU LEU PRO LEU ASP CYS GLY VAL SEQRES 17 A 379 PRO ASP ASN LEU SER MET ALA ASP PRO ASN ILE ARG PHE SEQRES 18 A 379 LEU ASP LYS LEU PRO GLN GLN THR GLY ASP HIS ALA GLY SEQRES 19 A 379 ILE LYS ASP ARG VAL TYR SER ASN SER ILE TYR GLU LEU SEQRES 20 A 379 LEU GLU ASN GLY GLN ARG ALA GLY THR CYS VAL LEU GLU SEQRES 21 A 379 TYR ALA THR PRO LEU GLN THR LEU PHE ALA MET SER GLN SEQRES 22 A 379 TYR SER GLN ALA GLY PHE SER ARG GLU ASP ARG LEU GLU SEQRES 23 A 379 GLN ALA LYS LEU PHE CYS ARG THR LEU GLU ASP ILE LEU SEQRES 24 A 379 ALA ASP ALA PRO GLU SER GLN ASN ASN CYS ARG LEU ILE SEQRES 25 A 379 ALA TYR GLN GLU PRO ALA ASP ASP SER SER PHE SER LEU SEQRES 26 A 379 SER GLN GLU VAL LEU ARG HIS LEU ARG GLN GLU GLU LYS SEQRES 27 A 379 GLU GLU VAL THR VAL GLY SER LEU LYS THR SER ALA VAL SEQRES 28 A 379 PRO SER THR SER THR MET SER GLN GLU PRO GLU LEU LEU SEQRES 29 A 379 ILE SER GLY MET GLU LYS PRO LEU PRO LEU ARG THR ASP SEQRES 30 A 379 PHE SER SEQRES 1 B 379 MET PRO HIS SER SER LEU HIS PRO SER ILE PRO CYS PRO SEQRES 2 B 379 ARG GLY HIS GLY ALA GLN LYS ALA ALA LEU VAL LEU LEU SEQRES 3 B 379 SER ALA CYS LEU VAL THR LEU TRP GLY LEU GLY GLU PRO SEQRES 4 B 379 PRO GLU HIS THR LEU ARG TYR LEU VAL LEU HIS LEU ALA SEQRES 5 B 379 SER LEU GLN LEU GLY LEU LEU LEU ASN GLY VAL CYS SER SEQRES 6 B 379 LEU ALA GLU GLU LEU ARG HIS ILE HIS SER ARG TYR ARG SEQRES 7 B 379 GLY SER TYR TRP ARG THR VAL ARG ALA CYS LEU GLY CYS SEQRES 8 B 379 PRO LEU ARG ARG GLY ALA LEU LEU LEU LEU SER ILE TYR SEQRES 9 B 379 PHE TYR TYR SER LEU PRO ASN ALA VAL GLY PRO PRO PHE SEQRES 10 B 379 THR TRP MET LEU ALA LEU LEU GLY LEU SER GLN ALA LEU SEQRES 11 B 379 ASN ILE LEU LEU GLY LEU LYS GLY LEU ALA PRO ALA GLU SEQRES 12 B 379 ILE SER ALA VAL CYS GLU LYS GLY ASN PHE ASN VAL ALA SEQRES 13 B 379 HIS GLY LEU ALA TRP SER TYR TYR ILE GLY TYR LEU ARG SEQRES 14 B 379 LEU ILE LEU PRO GLU LEU GLN ALA ARG ILE ARG THR TYR SEQRES 15 B 379 ASN GLN HIS TYR ASN ASN LEU LEU ARG GLY ALA VAL SER SEQRES 16 B 379 GLN ARG LEU TYR ILE LEU LEU PRO LEU ASP CYS GLY VAL SEQRES 17 B 379 PRO ASP ASN LEU SER MET ALA ASP PRO ASN ILE ARG PHE SEQRES 18 B 379 LEU ASP LYS LEU PRO GLN GLN THR GLY ASP HIS ALA GLY SEQRES 19 B 379 ILE LYS ASP ARG VAL TYR SER ASN SER ILE TYR GLU LEU SEQRES 20 B 379 LEU GLU ASN GLY GLN ARG ALA GLY THR CYS VAL LEU GLU SEQRES 21 B 379 TYR ALA THR PRO LEU GLN THR LEU PHE ALA MET SER GLN SEQRES 22 B 379 TYR SER GLN ALA GLY PHE SER ARG GLU ASP ARG LEU GLU SEQRES 23 B 379 GLN ALA LYS LEU PHE CYS ARG THR LEU GLU ASP ILE LEU SEQRES 24 B 379 ALA ASP ALA PRO GLU SER GLN ASN ASN CYS ARG LEU ILE SEQRES 25 B 379 ALA TYR GLN GLU PRO ALA ASP ASP SER SER PHE SER LEU SEQRES 26 B 379 SER GLN GLU VAL LEU ARG HIS LEU ARG GLN GLU GLU LYS SEQRES 27 B 379 GLU GLU VAL THR VAL GLY SER LEU LYS THR SER ALA VAL SEQRES 28 B 379 PRO SER THR SER THR MET SER GLN GLU PRO GLU LEU LEU SEQRES 29 B 379 ILE SER GLY MET GLU LYS PRO LEU PRO LEU ARG THR ASP SEQRES 30 B 379 PHE SER HET WJ6 A 401 64 HETNAM WJ6 1-[(2E)-4-{5-CARBAMOYL-2-[(1-ETHYL-3-METHYL-1H- HETNAM 2 WJ6 PYRAZOLE-5-CARBONYL)AMINO]-7-[3-(MORPHOLIN-4-YL) HETNAM 3 WJ6 PROPOXY]-1H-BENZIMIDAZOL-1-YL}BUT-2-EN-1-YL]-2-[(1- HETNAM 4 WJ6 ETHYL-3-METHYL-1H-PYRAZOLE-5-CARBONYL)AMINO]-7-METHYL- HETNAM 5 WJ6 1H-FURO[3,2-E]BENZIMIDAZOLE-5-CARBOXAMIDE FORMUL 3 WJ6 C44 H51 N13 O7 HELIX 1 AA1 HIS A 16 LEU A 36 1 21 HELIX 2 AA2 HIS A 42 LEU A 70 1 29 HELIX 3 AA3 ILE A 73 ARG A 78 1 6 HELIX 4 AA4 SER A 80 CYS A 88 1 9 HELIX 5 AA5 CYS A 91 SER A 108 1 18 HELIX 6 AA6 PHE A 117 LEU A 134 1 18 HELIX 7 AA7 ALA A 140 GLU A 149 1 10 HELIX 8 AA8 ALA A 156 TYR A 167 1 12 HELIX 9 AA9 TYR A 167 TYR A 186 1 20 HELIX 10 AB1 ALA A 262 TYR A 274 1 13 HELIX 11 AB2 SER A 280 LEU A 299 1 20 HELIX 12 AB3 SER A 324 GLN A 335 1 12 HELIX 13 AB4 HIS B 16 LEU B 36 1 21 HELIX 14 AB5 HIS B 42 LEU B 70 1 29 HELIX 15 AB6 ILE B 73 ARG B 78 1 6 HELIX 16 AB7 SER B 80 CYS B 88 1 9 HELIX 17 AB8 CYS B 91 SER B 108 1 18 HELIX 18 AB9 PHE B 117 LEU B 134 1 18 HELIX 19 AC1 ALA B 140 GLU B 149 1 10 HELIX 20 AC2 ALA B 156 TYR B 167 1 12 HELIX 21 AC3 TYR B 167 TYR B 186 1 20 HELIX 22 AC4 ALA B 262 TYR B 274 1 13 HELIX 23 AC5 SER B 280 LEU B 299 1 20 HELIX 24 AC6 SER B 324 GLN B 335 1 12 SHEET 1 AA1 4 ILE A 244 GLU A 249 0 SHEET 2 AA1 4 GLN A 252 GLU A 260 -1 O GLY A 255 N LEU A 247 SHEET 3 AA1 4 LEU A 198 PRO A 203 1 N LEU A 201 O GLU A 260 SHEET 4 AA1 4 CYS A 309 TYR A 314 1 O ILE A 312 N ILE A 200 SHEET 1 AA2 4 ILE B 244 GLU B 249 0 SHEET 2 AA2 4 GLN B 252 GLU B 260 -1 O GLY B 255 N LEU B 247 SHEET 3 AA2 4 LEU B 198 PRO B 203 1 N LEU B 201 O GLU B 260 SHEET 4 AA2 4 CYS B 309 TYR B 314 1 O ILE B 312 N ILE B 200 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000